Clinical Feasibility of Platinum-Based Chemotherapy Followed by Avelumab Maintenance after Enfortumab Vedotin plus Pembrolizumab in Metastatic Urothelial Carcinoma: A Case Series

Chemotherapy · Published 2026-05-21 · DOI 10.1159/000552622

Free full text

Authors (14)

Masaomi Ikeda, Satoshi Ichikawa, Shunsuke Ito, Kazuki Okumura, Yuriko Otsu, Izuru Shiba, Yutaka Shiono, Soichiro Shimura, Kohei Mori, Shuhei Hirano, Dai Koguchi, Hideyasu Tsumura, Daisuke Ishii, Kazumasa Matsumoto

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Ikeda, M., Ichikawa, S., Ito, S., et al. (2026). Clinical Feasibility of Platinum-Based Chemotherapy Followed by Avelumab Maintenance after Enfortumab Vedotin plus Pembrolizumab in Metastatic Urothelial Carcinoma: A Case Series. Chemotherapy. https://doi.org/10.1159/000552622

Related articles